Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Naomi Rachel Schechter, MD

    TitleAssociate Professor of Clinical Radiation Oncology
    SchoolKeck School of Medicine of USC
    DepartmentRadiation Oncology
    AddressGNH 1100 N. State Street
    Health Sciences Campus
    Los Angeles California 90033
    vCardDownload vCard
      Other Positions
      TitleDirector of Quality & Safety Keck Medical Center


      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Freedman GM, Fowble BL, Li T, Hwang ES, Schechter N, Devarajan K, Anderson PR, Sigurdson ER, Goldstein LJ, Bleicher RJ. Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J. 2014 Jul-Aug; 20(4):358-63. PMID: 24861613; PMCID: PMC4472437.
      2. Descovich M, Fowble B, Bevan A, Schechter N, Park C, Xia P. Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):91-9. PMID: 19395189.
        View in: PubMed
      3. Schechter N, Erwin WD, Yang DJ, Kim EE, Munden RF, Forster K, Taing LC, Cox JD, Macapinlac HA, Podoloff DA. Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2009 Oct; 36(10):1583-91. PMID: 19396440; PMCID: PMC2758190.
      4. Vitolo V, Millender LE, Quivey JM, Yom SS, Schechter N, Jereczek-Fossa BA, Milani F, Orecchia R, Xia P. Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy. Radiother Oncol. 2009 Feb; 90(2):213-20. PMID: 18926579.
        View in: PubMed
      5. Schechter N, Yang DJ, Azhdarinia A, Chanda M. Technologies for translational imaging using generators in oncology. Recent Pat Anticancer Drug Discov. 2007 Nov; 2(3):251-8. PMID: 18221069.
        View in: PubMed
      6. Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter N, Phillips TL, Fu KK, Eisele DW. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):152-9. PMID: 16904520.
        View in: PubMed
      7. Motwani SB, Strom EA, Schechter N, Butler CE, Lee GK, Langstein HN, Kronowitz SJ, Meric-Bernstam F, Ibrahim NK, Buchholz TA. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):76-82. PMID: 16765534.
        View in: PubMed
      8. Oh JL, Bonnen M, Outlaw ED, Schechter N, Perkins GH, Strom EA, Babiera G, Oswald MJ, Allen PK, Thames HD, Buchholz TA. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"? Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65(5):1345-52. PMID: 16750315.
        View in: PubMed
      9. Schechter N, Strom EA, Perkins GH, Arzu I, McNeese MD, Langstein HN, Kronowitz SJ, Meric-Bernstam F, Babiera G, Hunt KK, Hortobagyi GN, Buchholz TA. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol. 2005 Oct; 28(5):485-94. PMID: 16199989.
        View in: PubMed
      10. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter N, Hunt KK, Sahin AA, Buchholz TA. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jun 01; 62(2):351-7. PMID: 15890574.
        View in: PubMed
      11. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter N, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol. 2004 Dec 01; 22(23):4691-9. PMID: 15570071.
        View in: PubMed
      12. Yu TK, Whitman GJ, Thames HD, Buzdar AU, Strom EA, Perkins GH, Schechter N, McNeese MD, Kau SW, Thomas ES, Hortobagyi GN, Buchholz TA. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst. 2004 Nov 17; 96(22):1676-81. PMID: 15547180.
        View in: PubMed
      13. Schechter N, Wendt RE, Yang DJ, Azhdarinia A, Erwin WD, Stachowiak AM, Broemeling LD, Kim EE, Cox JD, Podoloff DA, Ang KK. Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck. J Nucl Med. 2004 Oct; 45(10):1683-7. PMID: 15471833.
        View in: PubMed
      14. Buchholz TA, Huang EH, Berry D, Pusztai L, Strom EA, McNeese MD, Perkins GH, Schechter N, Kuerer HM, Buzdar AU, Valero V, Hunt KK, Hortobagyi GN, Sahin AA. Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Aug 01; 59(5):1337-42. PMID: 15275718.
        View in: PubMed
      15. Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter N, Sahin AA, Middleton LP, Buchholz TA. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1074-9. PMID: 15234041.
        View in: PubMed
      16. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter N, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol. 2004 Jun 15; 22(12):2303-12. PMID: 15197191.
        View in: PubMed
      17. Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Sahin A, Schechter N, Valero V, Tucker SL, Buchholz TA. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):138-45. PMID: 15093909.
        View in: PubMed
      18. Garden AS, Asper JA, Morrison WH, Schechter N, Glisson BS, Kies MS, Myers JN, Ang KK. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer. 2004 Mar 15; 100(6):1171-8. PMID: 15022283.
        View in: PubMed
      19. O'Daniel JC, Dong L, Kuban DA, Liu H, Schechter N, Tucker SL, Rosen I. The delivery of IMRT with a single physical modulator for multiple fields: a feasibility study for paranasal sinus cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):876-87. PMID: 14967445.
        View in: PubMed
      20. Frank SJ, McNeese MD, Strom EA, Perkins G, Salehpour M, Schechter N, Buchholz TA. Advances in radiation treatments of breast cancer. Clin Breast Cancer. 2004 Feb; 4(6):401-6. PMID: 15023240.
        View in: PubMed
      21. Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter N, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TA. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol. 2003 Sep 01; 21(17):3244-8. PMID: 12947058.
        View in: PubMed
      22. Cox JD, Schechter N, Lee AK, Forster K, Stevens CW, Ang KK, Komaki R, Liao Z, Milas L. Uncertainties in physical and biological targeting with radiation therapy. Rays. 2003 Jul-Sep; 28(3):211-5. PMID: 15018309.
        View in: PubMed
      23. Yilmaz B, Goldberg LH, Schechter N, Kemp BL, Ruiz H. Basal cell nevus syndrome concurrent with adenoid cystic carcinoma of salivary gland. J Am Acad Dermatol. 2003 May; 48(5 Suppl):S64-6. PMID: 12734479.
        View in: PubMed
      24. Ballo MT, Bonnen MD, Garden AS, Myers JN, Gershenwald JE, Zagars GK, Schechter N, Morrison WH, Ross MI, Kian Ang K. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer. 2003 Apr 01; 97(7):1789-96. PMID: 12655537.
        View in: PubMed
      25. Yang DJ, Kim CG, Schechter N, Azhdarinia A, Yu DF, Oh CS, Bryant JL, Won JJ, Kim EE, Podoloff DA. Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents. Radiology. 2003 Feb; 226(2):465-73. PMID: 12563141.
        View in: PubMed
      26. Garden AS, Forster K, Wong PF, Morrison WH, Schechter N, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys. 2003 Feb 01; 55(2):322-8. PMID: 12527044.
        View in: PubMed
      27. Schechter N, Yang DJ, Azhdarinia A, Kohanim S, Wendt R, Oh CS, Hu M, Yu DF, Bryant J, Ang KK, Forster KM, Kim EE, Podoloff DA. Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody. Anticancer Drugs. 2003 Jan; 14(1):49-56. PMID: 12544258.
        View in: PubMed
      28. Yang DJ, Kim KD, Schechter N, Yu DF, Wu P, Azhdarinia A, Roach JS, Kalimi SK, Ozaki K, Fogler WE, Bryant JL, Herbst R, Abbruzzes J, Kim EE, Podoloff DA. Assessment of antiangiogenic effect using 99mTc-EC-endostatin. Cancer Biother Radiopharm. 2002 Apr; 17(2):233-45. PMID: 12030117.
        View in: PubMed
      29. Storey MR, Garden AS, Morrison WH, Eicher SA, Schechter N, Ang KK. Postoperative radiotherapy for malignant tumors of the submandibular gland. Int J Radiat Oncol Biol Phys. 2001 Nov 15; 51(4):952-8. PMID: 11704316.
        View in: PubMed
      30. Schechter N, Gillenwater AM, Byers RM, Garden AS, Morrison WH, Nguyen LN, Podoloff DA, Ang KK. Can positron emission tomography improve the quality of care for head-and-neck cancer patients? Int J Radiat Oncol Biol Phys. 2001 Sep 01; 51(1):4-9. PMID: 11516844.
        View in: PubMed
      31. Schechter N, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys. 2000 Mar 15; 46(5):1093-103. PMID: 10725618.
        View in: PubMed
      32. Schechter N, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998 May; 16(5):1916-21. PMID: 9586910.
        View in: PubMed
      33. Schechter N, Mychalczak B, Jones W, Spriggs D. Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. Gynecol Oncol. 1998 Feb; 68(2):183-92. PMID: 9514808.
        View in: PubMed